Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 25,190 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: PRE Clear all

Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions: Alteplase, Placebo Administration; Biological · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Baltimore, Maryland • Houston, Texas

Conditions: Prostate Cancer
Interventions: brachytherapy, radiation therapy; Radiation
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 8
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Urbana, Illinois + 5 more

Conditions: Dual Incontinence, Fecal Incontinence, Urinary Incontinence, Sacral Neuromodulation
Interventions: Neurometer; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Tourette Syndrome
Interventions: Valbenazine, Placebo oral capsule; Drug
Lead sponsor: Neurocrine Biosciences; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 48
States / cities: Sun City, Arizona • Little Rock, Arkansas • Rogers, Arkansas + 43 more

Conditions: Smoking
Interventions: echocardiogram plus albuterol, airway blood flow plus albuterol, Fluticasone propionate, placebo; Procedure · Drug
Lead sponsor: University of Miami; Other
Eligibility: 25 Years to 75 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Refractive Errors
Interventions: LID018869+RepleniSH, LID018869+Biotrue, Biofinity+RepleniSH, PV+Biotrue; Device
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Maitland, Florida

Conditions: Alcoholic Cirrhosis
Interventions: Placebo, SAMe 400 mg tablet; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • Indianapolis, Indiana

Conditions: Myelodysplastic Syndromes
Interventions: filgrastim, clofarabine, cytarabine, microarray analysis, biopsy; Biological · Drug · Genetic + 1 more
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 120 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Obesity, Food Habits
Interventions: General Nutrition Recommendations, Breakfast Recommendation, No Breakfast Recommendation; Behavioral
Lead sponsor: David Allison, Phd; Other
Eligibility: 20 Years to 65 Years
Enrollment: 309 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 4
States / cities: Birmingham, Alabama • Denver, Colorado • Boston, Massachusetts + 1 more

Conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
Interventions: therapeutic estradiol, exemestane, laboratory biomarker analysis, enzyme-linked immunosorbent assay; Biological · Drug · Other
Lead sponsor: University of Arizona; Other
Eligibility: Female only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Cancer of Gastrointestinal Tract
Interventions: In-Person Exercise Protocol, Virtual Exercise Protocol; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Fort Worth, Texas

Conditions: Cochlear Implants, Hearing Loss, Amusia
Interventions: CT Guided Cochlear Implant Programming; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cancer, Chemotherapy-induced Peripheral Neuropathy
Interventions: CIPN Assessment and Management Algorithm; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 226 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Spinal Cord Injury, Traumatic Spinal Cord Injury, Paraplegia and Tetraplegia, Metabolic Syndrome
Interventions: Galantamine Hydrobromide Extended Release; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 21 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: West Orange, New Jersey • Manhasset, New York • The Bronx, New York

Conditions: Sickle Cell Disease, Thalassemia, Hemoglobinopathy
Interventions: Biotin-labeled red blood cells; Biological
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Interventions: 18F-rhPSMA-7.3, PET/CT; Drug · Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Respiratory Distress Syndrome in Premature Infants, Very Low Birth Weight Baby
Interventions: iNO, Nitrogen; Drug · Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 1 Minute to 2 Minutes
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma

Conditions: Pulmonary Disease, Chronic Obstructive, Hypercapnia, Hypoxia
Interventions: Humidified nasal high flow with oxygen; Device
Lead sponsor: Temple University; Other
Eligibility: 40 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obstructive Sleep Apnea
Interventions: Propranolol Oral Tablet, Placebo Oral Tablet; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 20 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypoxic-Ischemic Encephalopathy
Interventions: Holding during cooling; Other
Lead sponsor: Alexa Craig; Other
Eligibility: 24 Hours to 3 Days
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Portland, Maine

Conditions: Type 2 Diabetes
Interventions: Exenatide, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 45 Years to 70 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Ovarian Neoplasms
Interventions: CleoDX ovarian cancer test; Diagnostic Test
Lead sponsor: Cleo Diagnostics Ltd; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 19
States / cities: Chandler, Arizona • Jacksonville, Florida • Miami, Florida + 15 more

Conditions: Shoulder Pain
Interventions: Biofreeze; Drug
Lead sponsor: Sport and Spine Rehab Clinical Research Foundation; Other
Eligibility: 18 Years to 64 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Healthy Gut Microbiota
Interventions: Prebiotic A - inulin, Prebiotic B - galactooligosaccharides(GOS), Prebiotic C - wheat dextrin; Dietary Supplement
Lead sponsor: Duke University; Other
Eligibility: 17 Years to 70 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer

Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment

Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome

Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment

Three Daily Wear Monthly Replacement Silicone Hydrogel Contact Lenses With Two Multi-purpose Disinfecting Solution Combinations

SAMe Trial for Patients With Alcoholic Cirrhosis

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes

Study of the Effectiveness of Breakfast Recommendations On Reducing Body Weight

Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

Exercise Regimens and Neoadjuvant Chemotherapy

CT Guided CI Programming

Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy

Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation

Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients

Propranolol for Sleep Apnea Therapy

Holding, Stress, and Bonding During Therapeutic Hypothermia

Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes

A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women With an Ovarian Mass

Effectiveness of Biofreeze® on Shoulder Pain and In-office Exercise Performance

Human Gut Microbiota and Prebiotic Response